Alessandra Daigneault serves as Executive at NRX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Alessandra Daigneault has executed 5 insider transactions totaling $442.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 2, 2021 involved exercising options for 18,420 shares valued at $56.5K.
Alessandra Daigneault currently holds 18,420 shares of NRX Pharmaceuticals, Inc. (NRXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alessandra Daigneault has been a net seller of NRXP stock. They have purchased $0 and sold $442.0K worth of shares.
Alessandra Daigneault's most recent insider trade was on Sep 2, 2021, when they sold 18,420 shares at $3.07 per share.
Get notified when new Form 4 filings are submitted
| 13,164 |
| $3.07 |
| Discretionary |
| Aug 23, 2021 | NRXP | $442.0K | Sale | 33,715 | $13.11 | Discretionary |
| Aug 19, 2021 | NRXP | $84.1K | Option Exercise | 27,395 | $3.07 | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 6,320 | $N/A | Discretionary |